With an eye on the lucrative U.S. market, Italy’s Angelini Pharma will acquire rare disease specialist Catalyst Pharmaceuticals and its potential blockbuster, Firdapse, for $4.1 billion. Rome-based ...

Rare-disease specialist Catalyst Pharmaceuticals is set to be acquired by healthcare group Angelini Pharma in a $4.1 billion deal. Angelini will pay $31.50 for each of Nasdaq-listed Catalyst’s ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Italian drugmaker Angelini Pharma is exploring a potential acquisition of Catalyst Pharmaceuticals Inc. as it looks at deals to expand its footprint globally, people familiar with the matter said.

If you were planning on buying a Meta Quest 3 or 3S anytime soon, now’s the time to pull the trigger, before the price increase goes live. Above, you’ll find links to all three Quest configurations at ...

GameSpot may receive revenue from affiliate and advertising partnerships for sharing this content and from purchases through links. Price hikes have been felt across the entire tech industry lately, ...

NewsChopper 2 flew over a stretch of Highway 82 where multiple law enforcement patrol vehicles could be seen in the area. According to the Barrow County Sheriff’s Office, the incident happened along ...

Dyad AI from JuliaHub is bringing an AI-for-Science environment to product development. Users can model and interrogate systems, research formulations, derive governing equations, assemble models, run ...

With the upcoming Ash and Iron update just days away, the Destiny 2 team released the sandbox updates coming with the Major Update. The community has welcomed some changes announced by Bungie. However ...

What if your next coding assistant didn’t just help you write code but also gave you complete control over your data, tools, and workflow—all without costing a dime? Enter Dyad, a innovative open ...